Human Somatotropin Market
1 Study Coverage
1.1 Human Somatotropin Product Introduction
1.2 Market by Type
1.2.1 Global Human Somatotropin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Powder
1.2.3 Solvent
1.3 Market by Application
1.3.1 Global Human Somatotropin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Growth Hormone Deficiency (GHD)
1.3.3 Turner Syndrome
1.3.4 Chronic Renal Insufficiency
1.3.5 Prader Willi Syndrome
1.3.6 Small for Gestational Age
1.3.7 SHOX Deficiency
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Somatotropin Sales Estimates and Forecasts 2017-2028
2.2 Global Human Somatotropin Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Somatotropin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Somatotropin Sales by Region
2.4.1 Global Human Somatotropin Sales by Region (2017-2022)
2.4.2 Global Sales Human Somatotropin by Region (2023-2028)
2.5 Global Human Somatotropin Revenue by Region
2.5.1 Global Human Somatotropin Revenue by Region (2017-2022)
2.5.2 Global Human Somatotropin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Somatotropin Sales by Manufacturers
3.1.1 Global Top Human Somatotropin Manufacturers by Sales (2017-2022)
3.1.2 Global Human Somatotropin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Somatotropin in 2021
3.2 Global Human Somatotropin Revenue by Manufacturers
3.2.1 Global Human Somatotropin Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Somatotropin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Somatotropin Revenue in 2021
3.3 Global Human Somatotropin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Somatotropin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Somatotropin Sales by Type
4.1.1 Global Human Somatotropin Historical Sales by Type (2017-2022)
4.1.2 Global Human Somatotropin Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Somatotropin Sales Market Share by Type (2017-2028)
4.2 Global Human Somatotropin Revenue by Type
4.2.1 Global Human Somatotropin Historical Revenue by Type (2017-2022)
4.2.2 Global Human Somatotropin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Somatotropin Revenue Market Share by Type (2017-2028)
4.3 Global Human Somatotropin Price by Type
4.3.1 Global Human Somatotropin Price by Type (2017-2022)
4.3.2 Global Human Somatotropin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Somatotropin Sales by Application
5.1.1 Global Human Somatotropin Historical Sales by Application (2017-2022)
5.1.2 Global Human Somatotropin Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Somatotropin Sales Market Share by Application (2017-2028)
5.2 Global Human Somatotropin Revenue by Application
5.2.1 Global Human Somatotropin Historical Revenue by Application (2017-2022)
5.2.2 Global Human Somatotropin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Somatotropin Revenue Market Share by Application (2017-2028)
5.3 Global Human Somatotropin Price by Application
5.3.1 Global Human Somatotropin Price by Application (2017-2022)
5.3.2 Global Human Somatotropin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Somatotropin Market Size by Type
6.1.1 North America Human Somatotropin Sales by Type (2017-2028)
6.1.2 North America Human Somatotropin Revenue by Type (2017-2028)
6.2 North America Human Somatotropin Market Size by Application
6.2.1 North America Human Somatotropin Sales by Application (2017-2028)
6.2.2 North America Human Somatotropin Revenue by Application (2017-2028)
6.3 North America Human Somatotropin Market Size by Country
6.3.1 North America Human Somatotropin Sales by Country (2017-2028)
6.3.2 North America Human Somatotropin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
7 Europe
7.1 Europe Human Somatotropin Market Size by Type
7.1.1 Europe Human Somatotropin Sales by Type (2017-2028)
7.1.2 Europe Human Somatotropin Revenue by Type (2017-2028)
7.2 Europe Human Somatotropin Market Size by Application
7.2.1 Europe Human Somatotropin Sales by Application (2017-2028)
7.2.2 Europe Human Somatotropin Revenue by Application (2017-2028)
7.3 Europe Human Somatotropin Market Size by Country
7.3.1 Europe Human Somatotropin Sales by Country (2017-2028)
7.3.2 Europe Human Somatotropin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Somatotropin Market Size by Type
8.1.1 Asia Pacific Human Somatotropin Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Somatotropin Revenue by Type (2017-2028)
8.2 Asia Pacific Human Somatotropin Market Size by Application
8.2.1 Asia Pacific Human Somatotropin Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Somatotropin Revenue by Application (2017-2028)
8.3 Asia Pacific Human Somatotropin Market Size by Region
8.3.1 Asia Pacific Human Somatotropin Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Somatotropin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Indonesia
8.3.9 Thailand
8.3.10 Malaysia
8.3.11 Philippines
8.3.12 Vietnam
9 Latin America
9.1 Latin America Human Somatotropin Market Size by Type
9.1.1 Latin America Human Somatotropin Sales by Type (2017-2028)
9.1.2 Latin America Human Somatotropin Revenue by Type (2017-2028)
9.2 Latin America Human Somatotropin Market Size by Application
9.2.1 Latin America Human Somatotropin Sales by Application (2017-2028)
9.2.2 Latin America Human Somatotropin Revenue by Application (2017-2028)
9.3 Latin America Human Somatotropin Market Size by Country
9.3.1 Latin America Human Somatotropin Sales by Country (2017-2028)
9.3.2 Latin America Human Somatotropin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Somatotropin Market Size by Type
10.1.1 Middle East and Africa Human Somatotropin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Somatotropin Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Somatotropin Market Size by Application
10.2.1 Middle East and Africa Human Somatotropin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Somatotropin Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Somatotropin Market Size by Country
10.3.1 Middle East and Africa Human Somatotropin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Somatotropin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Merck Serono
11.4.1 Merck Serono Corporation Information
11.4.2 Merck Serono Overview
11.4.3 Merck Serono Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck Serono Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Serono Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Corporation Information
11.5.2 F. Hoffmann-La Roche Overview
11.5.3 F. Hoffmann-La Roche Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 F. Hoffmann-La Roche Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Ferring Pharmaceuticals
11.6.1 Ferring Pharmaceuticals Corporation Information
11.6.2 Ferring Pharmaceuticals Overview
11.6.3 Ferring Pharmaceuticals Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ferring Pharmaceuticals Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ferring Pharmaceuticals Recent Developments
11.7 GeneScience Pharmaceuticals
11.7.1 GeneScience Pharmaceuticals Corporation Information
11.7.2 GeneScience Pharmaceuticals Overview
11.7.3 GeneScience Pharmaceuticals Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GeneScience Pharmaceuticals Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GeneScience Pharmaceuticals Recent Developments
11.8 Ipsen
11.8.1 Ipsen Corporation Information
11.8.2 Ipsen Overview
11.8.3 Ipsen Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Ipsen Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ipsen Recent Developments
11.9 LG Life Sciences
11.9.1 LG Life Sciences Corporation Information
11.9.2 LG Life Sciences Overview
11.9.3 LG Life Sciences Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 LG Life Sciences Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 LG Life Sciences Recent Developments
11.10 Sandoz International
11.10.1 Sandoz International Corporation Information
11.10.2 Sandoz International Overview
11.10.3 Sandoz International Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sandoz International Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sandoz International Recent Developments
11.11 Anhui Anke Biotechnology
11.11.1 Anhui Anke Biotechnology Corporation Information
11.11.2 Anhui Anke Biotechnology Overview
11.11.3 Anhui Anke Biotechnology Human Somatotropin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Anhui Anke Biotechnology Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Anhui Anke Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Somatotropin Industry Chain Analysis
12.2 Human Somatotropin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Somatotropin Production Mode & Process
12.4 Human Somatotropin Sales and Marketing
12.4.1 Human Somatotropin Sales Channels
12.4.2 Human Somatotropin Distributors
12.5 Human Somatotropin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Somatotropin Industry Trends
13.2 Human Somatotropin Market Drivers
13.3 Human Somatotropin Market Challenges
13.4 Human Somatotropin Market Restraints
14 Key Findings in The Global Human Somatotropin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Human Somatotropin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Powder
Table 3. Major Manufacturers of Solvent
Table 4. Global Human Somatotropin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Human Somatotropin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Human Somatotropin Sales by Region (2017-2022) & (MT)
Table 7. Global Human Somatotropin Sales Market Share by Region (2017-2022)
Table 8. Global Human Somatotropin Sales by Region (2023-2028) & (MT)
Table 9. Global Human Somatotropin Sales Market Share by Region (2023-2028)
Table 10. Global Human Somatotropin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Human Somatotropin Revenue Market Share by Region (2017-2022)
Table 12. Global Human Somatotropin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Human Somatotropin Revenue Market Share by Region (2023-2028)
Table 14. Global Human Somatotropin Sales by Manufacturers (2017-2022) & (MT)
Table 15. Global Human Somatotropin Sales Share by Manufacturers (2017-2022)
Table 16. Global Human Somatotropin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Human Somatotropin Revenue Share by Manufacturers (2017-2022)
Table 18. Human Somatotropin Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Human Somatotropin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Human Somatotropin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Somatotropin as of 2021)
Table 21. Human Somatotropin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Somatotropin Product Offered
Table 23. Date of Manufacturers Enter into Human Somatotropin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Somatotropin Sales by Type (2017-2022) & (MT)
Table 26. Global Human Somatotropin Sales by Type (2023-2028) & (MT)
Table 27. Global Human Somatotropin Sales Share by Type (2017-2022)
Table 28. Global Human Somatotropin Sales Share by Type (2023-2028)
Table 29. Global Human Somatotropin Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Human Somatotropin Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Human Somatotropin Revenue Share by Type (2017-2022)
Table 32. Global Human Somatotropin Revenue Share by Type (2023-2028)
Table 33. Human Somatotropin Price by Type (2017-2022) & (USD/MT)
Table 34. Global Human Somatotropin Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Human Somatotropin Sales by Application (2017-2022) & (MT)
Table 36. Global Human Somatotropin Sales by Application (2023-2028) & (MT)
Table 37. Global Human Somatotropin Sales Share by Application (2017-2022)
Table 38. Global Human Somatotropin Sales Share by Application (2023-2028)
Table 39. Global Human Somatotropin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Human Somatotropin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Human Somatotropin Revenue Share by Application (2017-2022)
Table 42. Global Human Somatotropin Revenue Share by Application (2023-2028)
Table 43. Human Somatotropin Price by Application (2017-2022) & (USD/MT)
Table 44. Global Human Somatotropin Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Human Somatotropin Sales by Type (2017-2022) & (MT)
Table 46. North America Human Somatotropin Sales by Type (2023-2028) & (MT)
Table 47. North America Human Somatotropin Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Human Somatotropin Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Human Somatotropin Sales by Application (2017-2022) & (MT)
Table 50. North America Human Somatotropin Sales by Application (2023-2028) & (MT)
Table 51. North America Human Somatotropin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Human Somatotropin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Human Somatotropin Sales by Country (2017-2022) & (MT)
Table 54. North America Human Somatotropin Sales by Country (2023-2028) & (MT)
Table 55. North America Human Somatotropin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Human Somatotropin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Human Somatotropin Sales by Type (2017-2022) & (MT)
Table 58. Europe Human Somatotropin Sales by Type (2023-2028) & (MT)
Table 59. Europe Human Somatotropin Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Human Somatotropin Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Human Somatotropin Sales by Application (2017-2022) & (MT)
Table 62. Europe Human Somatotropin Sales by Application (2023-2028) & (MT)
Table 63. Europe Human Somatotropin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Human Somatotropin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Human Somatotropin Sales by Country (2017-2022) & (MT)
Table 66. Europe Human Somatotropin Sales by Country (2023-2028) & (MT)
Table 67. Europe Human Somatotropin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Human Somatotropin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Human Somatotropin Sales by Type (2017-2022) & (MT)
Table 70. Asia Pacific Human Somatotropin Sales by Type (2023-2028) & (MT)
Table 71. Asia Pacific Human Somatotropin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Human Somatotropin Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Human Somatotropin Sales by Application (2017-2022) & (MT)
Table 74. Asia Pacific Human Somatotropin Sales by Application (2023-2028) & (MT)
Table 75. Asia Pacific Human Somatotropin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Human Somatotropin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Human Somatotropin Sales by Region (2017-2022) & (MT)
Table 78. Asia Pacific Human Somatotropin Sales by Region (2023-2028) & (MT)
Table 79. Asia Pacific Human Somatotropin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Human Somatotropin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Human Somatotropin Sales by Type (2017-2022) & (MT)
Table 82. Latin America Human Somatotropin Sales by Type (2023-2028) & (MT)
Table 83. Latin America Human Somatotropin Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Human Somatotropin Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Human Somatotropin Sales by Application (2017-2022) & (MT)
Table 86. Latin America Human Somatotropin Sales by Application (2023-2028) & (MT)
Table 87. Latin America Human Somatotropin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Human Somatotropin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Human Somatotropin Sales by Country (2017-2022) & (MT)
Table 90. Latin America Human Somatotropin Sales by Country (2023-2028) & (MT)
Table 91. Latin America Human Somatotropin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Human Somatotropin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Human Somatotropin Sales by Type (2017-2022) & (MT)
Table 94. Middle East and Africa Human Somatotropin Sales by Type (2023-2028) & (MT)
Table 95. Middle East and Africa Human Somatotropin Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Human Somatotropin Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Human Somatotropin Sales by Application (2017-2022) & (MT)
Table 98. Middle East and Africa Human Somatotropin Sales by Application (2023-2028) & (MT)
Table 99. Middle East and Africa Human Somatotropin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Human Somatotropin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Human Somatotropin Sales by Country (2017-2022) & (MT)
Table 102. Middle East and Africa Human Somatotropin Sales by Country (2023-2028) & (MT)
Table 103. Middle East and Africa Human Somatotropin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Human Somatotropin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Novo Nordisk Corporation Information
Table 106. Novo Nordisk Description and Major Businesses
Table 107. Novo Nordisk Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. Novo Nordisk Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Novo Nordisk Recent Developments
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Major Businesses
Table 112. Pfizer Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Pfizer Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Pfizer Recent Developments
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Major Businesses
Table 117. Eli Lilly Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Eli Lilly Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Eli Lilly Recent Developments
Table 120. Merck Serono Corporation Information
Table 121. Merck Serono Description and Major Businesses
Table 122. Merck Serono Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Merck Serono Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Merck Serono Recent Developments
Table 125. F. Hoffmann-La Roche Corporation Information
Table 126. F. Hoffmann-La Roche Description and Major Businesses
Table 127. F. Hoffmann-La Roche Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. F. Hoffmann-La Roche Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. F. Hoffmann-La Roche Recent Developments
Table 130. Ferring Pharmaceuticals Corporation Information
Table 131. Ferring Pharmaceuticals Description and Major Businesses
Table 132. Ferring Pharmaceuticals Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Ferring Pharmaceuticals Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Ferring Pharmaceuticals Recent Developments
Table 135. GeneScience Pharmaceuticals Corporation Information
Table 136. GeneScience Pharmaceuticals Description and Major Businesses
Table 137. GeneScience Pharmaceuticals Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. GeneScience Pharmaceuticals Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. GeneScience Pharmaceuticals Recent Developments
Table 140. Ipsen Corporation Information
Table 141. Ipsen Description and Major Businesses
Table 142. Ipsen Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Ipsen Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Ipsen Recent Developments
Table 145. LG Life Sciences Corporation Information
Table 146. LG Life Sciences Description and Major Businesses
Table 147. LG Life Sciences Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. LG Life Sciences Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. LG Life Sciences Recent Developments
Table 150. Sandoz International Corporation Information
Table 151. Sandoz International Description and Major Businesses
Table 152. Sandoz International Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. Sandoz International Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Sandoz International Recent Developments
Table 155. Anhui Anke Biotechnology Corporation Information
Table 156. Anhui Anke Biotechnology Description and Major Businesses
Table 157. Anhui Anke Biotechnology Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 158. Anhui Anke Biotechnology Human Somatotropin Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Anhui Anke Biotechnology Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Human Somatotropin Distributors List
Table 163. Human Somatotropin Customers List
Table 164. Human Somatotropin Market Trends
Table 165. Human Somatotropin Market Drivers
Table 166. Human Somatotropin Market Challenges
Table 167. Human Somatotropin Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Somatotropin Product Picture
Figure 3. Global Human Somatotropin Market Share by Type in 2021 & 2028
Figure 3. Powder Product Picture
Figure 4. Solvent Product Picture
Figure 5. Global Human Somatotropin Market Share by Application in 2021 & 2028
Figure 6. Growth Hormone Deficiency (GHD)
Figure 7. Turner Syndrome
Figure 8. Chronic Renal Insufficiency
Figure 9. Prader Willi Syndrome
Figure 10. Small for Gestational Age
Figure 11. SHOX Deficiency
Figure 12. Others
Figure 13. Human Somatotropin Report Years Considered
Figure 14. Global Human Somatotropin Sales 2017-2028 (MT)
Figure 15. Global Human Somatotropin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Human Somatotropin Revenue 2017-2028 (US$ Million)
Figure 17. Global Human Somatotropin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Human Somatotropin Sales Market Share by Region (2017-2022)
Figure 19. Global Human Somatotropin Sales Market Share by Region (2023-2028)
Figure 20. North America Human Somatotropin Sales YoY (2017-2028) & (MT)
Figure 21. North America Human Somatotropin Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Human Somatotropin Sales YoY (2017-2028) & (MT)
Figure 23. Europe Human Somatotropin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Human Somatotropin Sales YoY (2017-2028) & (MT)
Figure 25. Asia-Pacific Human Somatotropin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Human Somatotropin Sales YoY (2017-2028) & (MT)
Figure 27. Latin America Human Somatotropin Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Human Somatotropin Sales YoY (2017-2028) & (MT)
Figure 29. Middle East & Africa Human Somatotropin Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Human Somatotropin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Human Somatotropin in the World: Market Share by Human Somatotropin Revenue in 2021
Figure 32. Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Human Somatotropin Sales Market Share by Type (2017-2028)
Figure 34. Global Human Somatotropin Revenue Market Share by Type (2017-2028)
Figure 35. Global Human Somatotropin Sales Market Share by Application (2017-2028)
Figure 36. Global Human Somatotropin Revenue Market Share by Application (2017-2028)
Figure 37. North America Human Somatotropin Sales Market Share by Type (2017-2028)
Figure 38. North America Human Somatotropin Revenue Market Share by Type (2017-2028)
Figure 39. North America Human Somatotropin Sales Market Share by Application (2017-2028)
Figure 40. North America Human Somatotropin Revenue Market Share by Application (2017-2028)
Figure 41. North America Human Somatotropin Sales Share by Country (2017-2028)
Figure 42. North America Human Somatotropin Revenue Share by Country (2017-2028)
Figure 43. United States Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 45. Mexico Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Human Somatotropin Sales Market Share by Type (2017-2028)
Figure 47. Europe Human Somatotropin Revenue Market Share by Type (2017-2028)
Figure 48. Europe Human Somatotropin Sales Market Share by Application (2017-2028)
Figure 49. Europe Human Somatotropin Revenue Market Share by Application (2017-2028)
Figure 50. Europe Human Somatotropin Sales Share by Country (2017-2028)
Figure 51. Europe Human Somatotropin Revenue Share by Country (2017-2028)
Figure 52. Germany Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 53. France Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 54. UK Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Human Somatotropin Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Human Somatotropin Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Human Somatotropin Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Human Somatotropin Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Human Somatotropin Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Human Somatotropin Revenue Share by Region (2017-2028)
Figure 63. China Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 66. India Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 72. Vietnam Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Human Somatotropin Sales Market Share by Type (2017-2028)
Figure 74. Latin America Human Somatotropin Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Human Somatotropin Sales Market Share by Application (2017-2028)
Figure 76. Latin America Human Somatotropin Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Human Somatotropin Sales Share by Country (2017-2028)
Figure 78. Latin America Human Somatotropin Revenue Share by Country (2017-2028)
Figure 79. Mexico Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Human Somatotropin Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Human Somatotropin Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Human Somatotropin Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Human Somatotropin Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Human Somatotropin Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Human Somatotropin Revenue Share by Country (2017-2028)
Figure 88. Turkey Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 90. UAE Human Somatotropin Revenue (2017-2028) & (US$ Million)
Figure 91. Human Somatotropin Value Chain
Figure 92. Human Somatotropin Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
Industry Market Size
